CVI Holdings’s LYRA THERAPEUTICS INC LYRA Stock Holding History

CVI Holdings’s Portfolio LYRA Stock Details LYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,216	Closed	-$344K	–	884
2022 Q2	$344K	Buy	+1,216	New	+$331K	0.03%	445

Other funds holding LYRA

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

CVI Holdings's LYRA Position: Q3 2022 in Review

CVI Holdings sold out of LYRA THERAPEUTICS INC (LYRA) in Q3 2022, closing a stake of 1,216 shares — an estimated $344K sold.

CVI Holdings first reported a position in LYRA in Q2 2022 and held it in 1 quarter. The position peaked at $344K in Q2 2022. 37 funds tracked by Wall St. Rank hold LYRA as of Q3 2022.

CVI Holdings reported no remaining LYRA THERAPEUTICS INC position as of Q3 2022 after selling out during the quarter.
CVI Holdings sold 1,216 LYRA THERAPEUTICS INC shares in Q3 2022, an estimated $344K.
CVI Holdings first reported a position in LYRA THERAPEUTICS INC in Q2 2022 and held it in 1 quarter.
CVI Holdings's LYRA THERAPEUTICS INC position peaked at $344K in Q2 2022.
37 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q3 2022.

Based on CVI Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.